Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)

NCT00989261 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
333
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Daiichi Sankyo